L
ipoxins, formed by leukocytes during cell-cell interactions under a variety of conditions including inflammation, represent a unique class of lipid mediators with potent antiinflammatory actions (1) . The cellular mechanisms by which they reduce inflammation are of interest. Native lipoxin A 4 (LXA 4 ) and its stable analogues bind to a G protein-coupled receptor, and inhibit recruitment of neutrophils by attenuating their chemotaxis, adhesion, and transmigration across vascular endothelial and epithelial cells (for a review, see ref. 1) , and by diminishing chemokine production in intestinal mucosa (2) and fibroblasts (3) . In addition, LXA 4 may further facilitate resolution of inflammation by inhibiting superoxide formation (4) , by nonphlogistic activation of monocytes and macrophages (5, 6) and by inhibiting colonocyte apoptosis (2) . Intriguingly, aspirin can also trigger the transcellular biosynthesis of a series of 15-epimer (aspirin-triggered 15-epi-LXA 4 , ATL), which share many antiinflammatory activities with the native LXA 4 (7) . Thus, LXA 4 and ATL appear to serve as endogenous ''stop signals'' for neutrophil-mediated tissue injury (1, 8) .
Enhanced production of peroxynitrite (ONOO Ϫ ), formed in the reaction of nitric oxide (NO) with superoxide anion (O 2 Ϫ ), is a hallmark of a variety of inflammatory pathologies (9, 10) . The cytotoxic effects of ONOO Ϫ have been well documented. Recent results suggest a role for ONOO Ϫ in the regulation of intracellular signaling pathways that modulate inflammatory reactions by leukocytes. In particular, ONOO Ϫ activates ERK in neutrophils, leading to up-regulation of surface expression of CD11b͞ CD18 and increased polymorphonuclear leukocytes (PMN) adhesion to endothelial cells (11) . Scavenging of ONOO Ϫ reduces the influx of leukocytes into inflamed tissues, and prevents the development of tissue injury (12, 13) . ONOO Ϫ functions as an intracellular messenger to mediate IL-8 gene expression in lipopolysaccharide (LPS)-, TNF-␣-, or IL-1␤-stimulated human leukocytes (14, 15) through activation of the transcription factors nuclear factor-B (NF-B) and activator protein-1 (AP-1) (15, 16) . IL-8 plays a pivotal role in recruitment and activation of neutrophils (17) and monocytes (18) in various experimental models of inflammation (19, 20) . Agents that modulate ONOO Ϫ formation and subsequent IL-8 production may, therefore, possess potent antiinflammatory properties.
In the present experiments, we studied the impact of ATL and LXA 4 on LPS-stimulated ONOO Ϫ formation, NF-B and AP-1 activation, and IL-8 gene expression in human leukocytes. We used two distinct metabolically stable analogues of ATL, 15(R͞S)-methyl LXA 4 and 15-epi-16-p-fluorophenoxy-LXA 4 , here denoted ATL 1 and ATL 2 , respectively, and 16-phenoxy-LXA 4 , a stable analogue of LXA 4 . These analogues were designed to retain the bioactivity of native lipoxins and ATL by resisting their rapid enzymatic inactivation in tissues (21, 22) .
Materials and Methods
Materials. Stable analogs of LXA 4 and 15-epi-LXA 4 were prepared by total organic synthesis as in ref. 21 . Structures were confirmed by reversed phase-HPLC, NMR, and mass spectral analysis. Stock solutions were stored at Ϫ80°C in 99% ethanol. Vehicle controls comprised dilutions of the solvent to the highest concentration of lipoxins used in the experiments (maximal ethanol concentration 0.01%). ONOO Ϫ was obtained from Alexis (San Diego).
Cell Stimulation. Venous blood (anticoagulated with sodium heparin, 50 units͞ml) was obtained from healthy volunteers who had denied taking any medication for at least 2 weeks. The Clinical Research Committee approved the experimental protocols. PMN were isolated as described (23) . Whole blood This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: LXA4, lipoxin A4 (5S,6R,15S-trihydorxy-7,9,13-trans-11-cis-eicosatetraenoic acid); ATL, aspirin-triggered 15-epi-LXA4; LPS, lipopolysaccharide; DHR 123, dihydrorhodamine 123; DAF, diaminofluorescein diacetate; RFU, relative fluorescence units; PMN, polymorphonuclear leukocytes; NF-B, nuclear factor-B; AP-1, activator protein-1. § To whom reprint requests should be addressed at: Research Center, Maisonneuve-Rosemont Hospital, 5415 Boulevard de l'Assomption, Montré al, QC, Canada H1T 2M4. E-mail: janos.g.filep@umontreal.ca. aliquots or isolated PMN (5 ϫ 10 6 cells per ml) in sterile microcentrifuge tubes were placed on a rotator, incubated for 15 min with lipoxins, and challenged with LPS (1 g͞ml) or ONOO Ϫ (80 M) at 37°C in 5% CO 2 atmosphere. At the designated time points, the plasma was harvested and stored at Ϫ20°C for later cytokine analysis. Cells were processed as described below. (24) . DHR 123 (20 M, Molecular Probes) was added to some samples during the last 60 min of incubation in the presence or absence of L-NAME (1 mM), an inhibitor of NO synthases. Following lysis of erythrocytes, PMN, monocytes, and lymphocytes were gated by their forward and side scatter characteristics, and fluorescence was analyzed by a flow cytometer (FACScan, Becton Dickinson) (14) .
PMN extracts (prepared as in ref . 11) were analyzed for the presence of nitrotyrosine, a ''fingerprint'' of ONOO Ϫ (10), by Western blotting using a horseradish peroxidase-conjugated goat antinitrotyrosine antibody (NY20H-G1a, Academy BioMedical Co., Houston). Nitrated proteins were quantified by an enzyme immunoassay (Cayman Chemicals, Ann Arbor, MI), using nitrotyrosine as standard. The detection limit of the assay was 2 ng͞ml. Intra-and interassay coefficients of variation were typically Ͻ6%.
NO and Superoxide Production. Intracellular formation of NO was monitored by flow cytometry following incorporation of diaminofluorescein diacetate (DAF, 5 M, CLONTECH) into PMN in accordance with the supplier's protocol. Superoxide production was determined as superoxide dismutase-inhibitable reduction of ferricytochrome c (23).
IL-8 Protein and RNase Protection
Assay. Plasma concentrations of IL-8 were determined by a selective ELISA (BioSource International, Camarillo, CA). For RNase protection assays, 50 l of blood was mixed with an equal volume of lysis͞denaturation solution (Ambion, Austin, TX). Labeled probes for human IL-8 and GAPDH were synthesized and the assay was performed with the Direct Protect kit (Ambion) as described (14) .
NF-B and AP-1. Intranuclear, DNA bound NF-B͞p65 and AP1͞c-Fos were measured with a flow cytometric assay (15) and were used as an estimate of NF-B and AP-1 activity in the cell, respectively. This assay allows simultaneous detection of DNAbound transcription factors in PMN and mononuclear leukocyte populations in whole blood. Leukocyte nuclei were prepared using the Cycletest Plus DNA reagent kit (Becton Dickinson), first stained with rabbit polyclonal anti-human NF-B͞p65 or c-Fos antibodies, or with normal rabbit IgG (to assess nonspecific binding of IgG to nuclei) and then with FITC-conjugated anti-rabbit IgG antibody (all from Santa Cruz Biotechnology) and propidium iodide. Singlet cell nuclei were gated using the doublet-discrimination module and fluorescence intensity for both PMN and mononuclear cell nuclei was analyzed with a FACScan flow cytometer using the LYSIS II and CELLFIT software.
Neutrophil Viability and Apoptosis. PMN viability was assessed by flow cytometry immediately after staining with propidium iodide (0.5 g͞ml). The binding of phycoerythrin-labeled annexin V was used as a sensitive marker of PMN apoptosis (25) .
Statistical Analysis. Results are expressed as means Ϯ SEM. Statistical comparisons were made by ANOVA using ranks (Kruskal-Wallis test) followed by Dunn's multiple contrast hypothesis tests to identify differences between various treatments. Values of P Ͻ 0.05 were considered significant.
Results

LXA4͞ATL Analogues Inhibit LPS-Induced IL-8 Production and IL-8
mRNA Expression. Incubation of human whole blood with LPS evoked increases in IL-8 production that were markedly reduced by LXA 4 analogues in a concentration-dependent manner (EC 50 , 16-26 nM) assessed at 4 and 24 h post-LPS administration ( Fig.  1 ). Apparent maximum inhibition was achieved at Ϸ500 nM with 16-phenoxy-LXA 4 , ATL 1 , and ATL 2 being virtually equally potent inhibitors, whereas 15-deoxy-LXA 4 was without effect (Fig. 1) . None of the LXA 4 analogues by themselves affected baseline IL-8 production (data not shown).
Next, we examined whether LXA 4 ͞ATL actions involved preor posttranscriptional events. Results shown in Inhibition of ONOO ؊ Formation. We assessed intracellular rhodamine fluorescence at 4 h post-LPS administration when the highest level of NO-dependent DHR 123 oxidation can be detected (14) . LPS evoked 4-to 6-fold increases in rhodamine fluorescence in PMN, monocytes, and lymphocytes, which were prevented by ATL 1 in a concentration-dependent fashion (Fig.  4A) . Similar inhibition was obtained with ATL 2 and 16-phenoxy-LXA 4 , but not with 15-deoxy-LXA 4 (Fig. 4B) . LPS-evoked increases in rhodamine fluorescence were also reduced by L-NAME (Fig. 4B ), indicating that a large portion of DHR 123 oxidation was due to ONOO Ϫ formation (14, 24) . No additive inhibition was observed with a combination of LXA 4 analogues and L-NAME (Fig. 4B) . Furthermore, addition of the NO donor spermine NONOate (0.5 mM) to L-NAME-treated PMN restored DHR 123 oxidation [rhodamine fluorescence in relative fluorescence units (RFU); control, 13 Ϯ 1; LPS, 56 Ϯ 6; L-NAMEϩLPS, 25 Ϯ 2; spermine NONOateϩL-NAMEϩLPS, 54 Ϯ 5; n ϭ 5, P Ͼ 0.1 compared with LPS]. LPS gave increases, as expected, in both O 2 Ϫ and NO production with isolated PMN (Fig. 5) . LXA 4 analogues, with the exception of 15-deoxy-LXA 4, attenuated LPS-stimulated O 2 Ϫ generation (Fig. 5) . LPS-induced increases in the fluorescence of the NO-sensitive dye DAF were significantly higher in the presence of ATL 1 , ATL 2 , or 16-phenoxy-LXA 4 (Fig. 5) . These analogues reduced LPS-induced, NO-dependent DHR 123 oxidation parallel with inhibition of O 2 Ϫ generation (Fig. 5 ). To provide further evidence for ONOO Ϫ formation, we quantified PMN nitrotyrosine content. PMN exposed to LPS contained significantly higher amounts of nitrotyrosine than unchallenged cells (Fig. 6) , and the increases were comparable to those evoked by 80 M ONOO Ϫ . Prior treatment of PMN with ATL 1 , ATL 2 , or 16-phenoxy-LXA 4 , but not with 15-deoxy-LXA 4 , resulted in marked reductions in LPS-induced tyrosine nitration (Fig. 6A) .
Western blotting of proteins in lysates of LPS-treated PMN revealed the appearance of nitrotyrosine-positive staining of proteins with 16, 20, 26, [28] [29] [30] 36 , and 48 kDa molecular mass, corresponding to those nitrated by exogenous ONOO Ϫ (Fig. 6B) . LPS-induced increases in tyrosine nitration were attenuated by ATL 1 , ATL 2 , and 16-phenoxy-LXA 4 , but not by 15-deoxy-LXA 4 (Fig. 6B) . Immunospecificity of the primary antibody for nitrotyrosine was confirmed when immunoreactivity of PMN extracts was abolished by absorption of antinitrotyrosine activity with soluble 10 mM nitrotyrosine, but was unaffected by 10 mM aminotyrosine (data not shown).
Inhibition of LPS-Stimulated Nuclear Accumulation of AP-1 and NF-B.
LPS, as expected, mobilized NF-B͞p65 and c-Fos to the nucleus (i.e., the increased fluorescence represents increased amounts of NF-B or AP-1 bound to DNA), and this mobilization was attenuated by ATL 1 (Fig. 7 A and B) . Immunostaining was completely blocked by preincubation of the antibodies with the appropriate blocking peptides. Stimulation of leukocytes in the presence of ATL 1 , ATL 2 , or 16-phenoxy-LXA 4 gave quantitatively similar results with respect to the extent of inhibition of LPS-evoked nuclear accumulation of NF-B͞p65 and AP-1͞c-Fos in both PMN and mononuclear cells (Fig. 7C) . None of the LXA 4 analogues affected immunostaining of nuclei for NF-B͞ p65 and c-Fos in unchallenged cells (data not shown).
LXA4 Analogues and Neutrophil Viability and Apoptosis. Because increased NO and ONOO
Ϫ formation may be associated with changes in cell survival (10), we studied the impact of LXA 4 analogues on neutrophil survival. Consistent with previous studies (26) , after 24 h in vitro, LPS increased the percentage of viable PMN and reduced the percentage of annexin V-positive cells. However, none of the LXA 4 analogues tested significantly affected the ability of LPS to prolong neutrophil survival and delay apoptosis (Fig. 8) .
Discussion
The present results provide evidence for a mechanism by which LXA 4 and ATL may affect the inflammatory process by inhibiting ONOO Ϫ formation by leukocytes. This is associated with attenuation of nuclear accumulation of transcription factors NF-B and AP-1, and subsequent reduction of IL-8 gene expression and production. Because recent studies have increasingly pointed to the pivotal role of IL-8 in directing leukocyte traffic into inflamed areas, our observations bear directly on the mechanism for the antiinflammatory effects of LXA 4 and, in particular, the aspirin-triggered epimer, ATL. Bacterial LPS is one of the most potent stimuli for IL-8 expression in most cell types, including human leukocytes (27) . In addition to the available in vitro data (2, 3, 28), here we have shown that incubation of human whole blood samples with ATL 1 , ATL 2 , and 16-phenoxy-LXA 4 at nanomolar concentrations results in concentration-dependent attenuation of LPSinduced IL-8 release. The higher concentrations required in whole blood to effectively inhibit IL-8 production than in isolated cells might reflect interactions of LXA 4 analogues with serum components such as albumin. Nevertheless, our results demonstrate that LXA 4 ͞ATL analogues are potent inhibitors of key responses of leukocytes in amplifying the inflammatory response in whole blood and in a culture milieu that is biologically relevant. Thus, our results enhance earlier findings with intestinal epithelial cells (2, 28) and fibroblasts (3) and confirm the capability of LXA 4 analogues to regulate proinflammatory cytokine production in leukocytes. Furthermore, these LXA 4 ͞ ATL analogues continue to demonstrate bioactivity for at least 24 h after their bolus addition to whole blood samples.
The present results indicate that metabolically stable LXA 4 ͞ ATL analogues markedly attenuate ONOO Ϫ formation by human leukocytes. To monitor intracellular ONOO Ϫ formation, we monitored NO-dependent oxidation of DHR 123 to rhodamine and quantified nitration of protein tyrosine residues, a specific ''fingerprint'' of ONOO Ϫ (10), and obtained consistent results with these two assays. A significant portion of rhodamine fluorescence in LPS-stimulated leukocytes can be attributed to ONOO Ϫ , because it depends on NO-related species-it can be inhibited by L-NAME-whereas NO per se does not oxidize DHR 123 (24) . Further, the NO donor spermine NONOate restored DHR 123 oxidation in L-NAME-treated PMN, indicating that the effect of L-NAME in the DHR 123 assay was not due to inhibition of assembly of the NADPH oxidase. The lack of additive inhibitory actions of LXA 4 analogues and L-NAME on DHR 123 oxidation would suggest that these compounds inhibited the same reaction-i.e., the ONOO There is evidence that the nitration yield may be increased via the formation of the nitrosoperoxycarbonate anion from physiologic concentrations of CO 2 and bicarbonate, thereby enhancing the reactivity of ONOO Ϫ (29) . Although nitrotyrosine formation is considered as a specific ''fingerprint'' of ONOO Ϫ (10), some studies proposed additional pathways of tyrosine nitration (30) , indicating that nitrotyrosine may rather serve as an indicator of ''reactive nitrogen species'' (31 We were surprised to observe increased DAF fluorescence in the presence of LXA 4 analogues plus LPS as compared with LPS alone. However, it is unlikely that such increases might mirror elevated NO formation, because LXA 4 analogues by themselves did not enhance DAF fluorescence. Indeed, when NO is produced in relative excess to superoxide (i.e., unchanged NO synthesis and reduced superoxide generation) NO 2 from ONOO Ϫ decomposition may react with NO to form more nitrosating intermediates, leading to increased DAF fluorescence. These competing reactions might represent important pathways by which the oxidative chemistry of NO, O 2 Ϫ , and ONOO Ϫ may be modulated.
Consistent with previous reports, we detected NF-B and AP-1 activation in response to LPS in both PMN and mononuclear leukocytes by using a flow-cytometric assay. Although this system permits simultaneous detection of nucleus-bound transcription factors in both PMN and mononuclear leukocytes without prior isolation of these cells, nuclei from monocytes and lymphocytes cannot be analyzed separately. Therefore, the quantities of transcription factors present in PMN and monocytes cannot be compared.
Despite their predominantly cytoplasmic localization in resting cells, low amounts of NF-B͞p65 and c-Fos DNA-binding activities can be observed in the nuclei of unstimulated PMN and mononuclear cells (refs. 35 and 36 , and the present study), and this was not attributable to cytosolic contamination of the nuclei. Although the significance of these observations is unclear, constitutive nuclear NF-B has been proposed to contribute to constitutive expression of transcripts encoding B-dependent genes. Of interest, none of the LXA 4 analogues affected the nuclear presence of NF-B in unchallenged cells, indicating the existence of a mechanism distinct from that inducing NF-B translocation after cell stimulation. On the other hand, LXA 4 ͞ ATL analogues effectively suppressed LPS-evoked nuclear ac- cumulation of NF-B and AP-1. Because inhibition of NF-B activation results in about 75% inhibition of IL-8 release, and exogenous ONOO Ϫ can increase nuclear binding of NF-B and AP-1 in both PMN (15) and mononuclear cells (15, 16) , it is likely that AP-1 may act in concert with NF-B to induce IL-8 production. The mechanism by which ONOO Ϫ increases nuclear binding of NF-B is not fully understood. The positive correlation of phosphorylation and nitration of tyrosine residues in IB-␣ with NF-B translocation (16) would suggest that LXA 4 ͞ ATL analogues might have protected IB-␣ from nitration by ONOO Ϫ , thereby preventing activation of NF-B. Inhibition of NF-B has been suggested to contribute considerably to the antiinf lammatory actions of aspirin (37) . Extending these observations, our results suggest another mechanism to inhibit NF-B activation in leukocytes-i.e., through induction of 15-epi-LXA 4 .
PMN survival is contingent on rescue from apoptosis by signals from the environment. LPS can prolong PMN survival by delaying apoptosis (26) . However, LXA 4 analogues did not affect these actions of LPS, indicating that the signaling pathway that mediates the apoptosis delaying action of LPS is not sensitive to LXA 4, nor does it involve ONOO Ϫ . The present observations coupled with the inhibitory actions of LXA 4 and ATL on the expression of leukocyte adhesion molecules (1, 7) may represent important components of the ''stop signaling'' for leukocyte trafficking into inflamed tissues. Decreased ONOO Ϫ formation is also consistent with a reduced cytotoxicity. The observations that LXA 4 analogues are potent inhibitors of ONOO Ϫ formation and IL-8 production by human leukocytes are important additions to the bioactivity profile of these compounds and suggest a role for LXA 4 ͞ATL analogues as potential therapeutic modifiers of diseases associated with enhanced ONOO Ϫ formation.
